---
trial_id: 501
discovery_date: 2022-04-07 15:47:22.221707
date: 2022-04-07 15:47:22.221707
title: "Post-authorization safety study to check the potential association between the safety
profile of beta interferon 1a and the body mass index or pharmacodynamics during the
titration phase"
summary: |
  <p>EudraCT Number: 2006-000606-23<br />Sponsor Protocol Number: 26756<br />Sponsor Name: Merck, S.L.<br />Start Date: 2006-11-23<br />Medical condition: Not applicalbe<br />Disease: <br />Version: 14.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000606-23/ES">ES</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-000606-23'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2006-000606-23<br />Sponsor Protocol Number: 26756<br />Sponsor Name: Merck, S.L.<br />Start Date: 2006-11-23<br />Medical condition: Not applicalbe<br />Disease: <br />Version: 14.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000606-23/ES">ES</a> (Completed)</p>